Term
Class IA: Antiarrhythmics |
|
Definition
Na+ fast channel blockers (and K+ prolongs repolarization) "state dependent blockade" preferentially in the open or activated state Increases AP duration and effective refractory period |
|
|
Term
|
Definition
Class IA antiarrhythmic (Na+ channel blocker) Also causes muscarinic receptor blockade which can increase HR and AV conduction (proarrhythmic) May also cause vasodilation via alpha block w/ possible reflex tachycardia Use: many arrhythmias but in A-fib need inital digitalization to slow AV conduction AE: cinchonism (GI, tinnitus, ocular dysfunction, CNS excitation), hypotension, increases QT interval assoc w/ syncope/torsades DI: hyperkalemia (b/c drug is a weak base it can increase its absorption) |
|
|
Term
|
Definition
Class 1A: antiarrhythmic (Na+ channel blocker) Less muscarinic block than quinidine & NO alpha block Metabolized via N-acetyltransferase to an active metabolite (therefore 2 active metabolites) AE: SLE-like syndrome (more likely w/ slow acetylators), hematotoxicity (thrombocytopenia, agranulocytosis), torsades |
|
|
Term
Class IB antiarrhythmics (lidocaine/mexiletine/tocainide) |
|
Definition
Block fast Na+ channels ONLY Block inactivated channels w/ preference for tissues partly depolarized (ischemic tissues) leads to less excitability for hypoxic heart muscle Decreases AP duration leading to increased time of diastole and decreased HR Lidocaine: local anesthetic (IV only) Used: post MI for ventricular arrhythmias, open heart surgery, digoxin toxicity SE: seizures, least cardiotoxic Mexiletine/Tocainide: oral but same uses |
|
|
Term
Class IC: antiarrhythmics |
|
Definition
Flecainide: blocks fast Na+ channels esp. in the His-Purkinje tissue NOT used b/c of proarrhythmogenic effects leading to increased sudden death post MI and when used in V-tach |
|
|
Term
|
Definition
Beta Blockers Prevent Beta receptor activation which would normally increase cAMP Decreases SA and AV nodal activity Decreases Slope of phase 4 pacemaker AP Propranolol + Acebutolol, Esmolol (last 2 are cardio selective) Uses: prophylaxis post MI supraventricular tachyarrhythmias |
|
|
Term
Class III: antiarrhythmics |
|
Definition
K+ channel blockers Delays the K+ current that allows repolarization (phase 3, increases APD & ERP) |
|
|
Term
|
Definition
Class III: antiarrhythmic (K+ channel blocker, rectifier current which slows phase 3 repolarization) Mimics actually classes I, II, III, and IV Uses: MOST effective antiarrhythmic Binds extensively to tissues so 1/2 life = 80d SE: Pulmonary fibrosis Blue pigmentation of skin/thyroid dysfunction Phototoxicity Corneal deposits Torsades (anything that involves the K+ channel is prone to this b/c of a genetic mutation that exists) |
|
|
Term
|
Definition
Class III: antiarrhythmic K+ channel blocker that slows phase 3 Beta 1 blockade which slows HR and AV conduction Use: life threatening ventricular arrhythmias SE: torsades |
|
|
Term
Class IV: antiarrhythmics |
|
Definition
Slow Ca2+ channel blockers, (phase 0 & 4) Decrease SA and AV nodal activity Verapamil >Diltiazem (rest of CCB's end in dipines) Uses: SVT's SE: constipation (Verapamil), dizziness, flushing, hypotension, AV block DI: additive AV block w/ B-blockers, digoxin Verapamil displaces digoxin from tissue-binding site |
|
|
Term
|
Definition
unclassified antiarrhythmic Nucleoside that activates adenosine receptors and causes a decrease in cAMP (K+ efflux & hyperpolarization) Uses: DOC for paroxysmal SVT's (can do valsalva/carotid sinus massage) & AV nodal arrhythmias SE: flushing, sedation, dyspnea Antagonized by theophylline |
|
|
Term
|
Definition
unclassified antiarrhythmic Use: torsades (pt w/ long QT syndrome) Drugs causing torsades: K+ channel blockers (I,III) Antipsychotics (thioridazine) TCA's |
|
|